These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8090451)

  • 21. Exercise-induced central retinal vein thrombosis: possible involvement of hemorheological disturbances. A case report.
    Gaudard A; Varlet-Marie E; Monnier JF; Janbon Ch; Quéré I; Bressolle F; Brun JF
    Clin Hemorheol Microcirc; 2002; 27(2):115-22. PubMed ID: 12237481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions.
    Appiah AP; Trempe CL
    Ophthalmology; 1989 Mar; 96(3):364-6. PubMed ID: 2710528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age.
    Lahey JM; Tunç M; Kearney J; Modlinski B; Koo H; Johnson RN; Tanaka S
    Ophthalmology; 2002 Jan; 109(1):126-31. PubMed ID: 11772591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study.
    Sperduto RD; Hiller R; Chew E; Seigel D; Blair N; Burton TC; Farber MD; Gragoudas ES; Haller J; Seddon JM; Yannuzzi LA
    Ophthalmology; 1998 May; 105(5):765-71. PubMed ID: 9593373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central retinal vein occlusion and pseudoexfoliation syndrome.
    Karagiannis D; Kontadakis GA; Klados NE; Tsoumpris I; Kandarakis AS; Parikakis EA; Georgalas I; Tsilimbaris MK
    Clin Interv Aging; 2015; 10():879-83. PubMed ID: 26056437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion?
    Gumus K; Kadayifcilar S; Eldem B; Saracbasi O; Ozcebe O; Dundar S; Kirazli S
    Clin Exp Ophthalmol; 2006; 34(4):305-11. PubMed ID: 16764648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central retinal vein occlusion risk profile: a case-control study.
    Shahsuvaryan ML; Melkonyan AK
    Eur J Ophthalmol; 2003 Jun; 13(5):445-52. PubMed ID: 12841567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bilateral central retinal vein occlusion and circulating anticoagulant].
    Lureau MA; Glacet-Bernard A; Coscas G
    J Fr Ophtalmol; 1995; 18(6-7):468-72. PubMed ID: 7560789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ophthalmodynamometric differences between ischemic vs nonischemic retinal vein occlusion.
    Jonas JB; Harder B
    Am J Ophthalmol; 2007 Jan; 143(1):112-6. PubMed ID: 17101111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mean platelet volume and central retinal vein occlusion in hypertensive patients.
    Bawankar P; Samant P; Lahane T; Parekh R; Lahane S
    Can J Ophthalmol; 2019 Apr; 54(2):275-279. PubMed ID: 30975354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central retinal vein occlusion case-control study.
    Koizumi H; Ferrara DC; Bruè C; Spaide RF
    Am J Ophthalmol; 2007 Dec; 144(6):858-863. PubMed ID: 17916319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central retinal vein occlusion associated with cilioretinal artery occlusion.
    Hayreh SS; Fraterrigo L; Jonas J
    Retina; 2008 Apr; 28(4):581-94. PubMed ID: 18398361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LABORATORY EVALUATION OF HYPERCOAGULABLE STATES IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION WHO ARE LESS THAN 56 YEARS OF AGE.
    Liu Q; Lahey JM; Karlen R; Stewart JM
    Retina; 2018 Jun; 38(6):1175-1179. PubMed ID: 28613222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion.
    Bandello F; Viganò D'Angelo S; Parlavecchia M; Tavola A; Della Valle P; Brancato R; D'Angelo A
    Thromb Haemost; 1994 Jul; 72(1):39-43. PubMed ID: 7974373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Beri M; Podhajsky P
    Ophthalmology; 2004 Jan; 111(1):133-41. PubMed ID: 14711725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D Deficiency in Patients with Central Retinal Vein Occlusion: A Case Control Study.
    Epstein D; Kvanta A; Lindqvist PG
    Curr Eye Res; 2017 Mar; 42(3):448-451. PubMed ID: 27348601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors associated with branch vs. central retinal vein occlusion.
    Appiah AP; Trempe CL
    Ann Ophthalmol; 1989 Apr; 21(4):153-5, 157. PubMed ID: 2729819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalent misconceptions about acute retinal vascular occlusive disorders.
    Hayreh SS
    Prog Retin Eye Res; 2005 Jul; 24(4):493-519. PubMed ID: 15845346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma.
    Wittström E; Ponjavic V; Lövestam-Adrian M; Larsson J; Andréasson S
    Acta Ophthalmol; 2010 Feb; 88(1):86-90. PubMed ID: 19432876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for central retinal vein occlusion in young adults.
    Chen TY; Uppuluri A; Zarbin MA; Bhagat N
    Eur J Ophthalmol; 2021 Sep; 31(5):2546-2555. PubMed ID: 33008264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.